Welchol (Colesevelam HCl) Patent Expiration, LOE Window & CMS Spending

Welchol (Colesevelam HCl) by Cosette: Off-Patent Genericized (AB Competition), 11 AB generics, $5.2M 2024 CMS Part D & Medicaid spend, and 5 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorCosette
FDA Application & PathwayN021176 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors11
2024 CMS Total Public Spend$5.2M
2024 Medicare Part D Spend$4.2M
2024 Medicaid Spend$1.0M
Reported Wholesale Price Change (CA SB 17)5 WAC filings (max 32.9% 2-yr change)